Iovance Biotherapeutics, Inc. (IOVA) Analyst Forecast

$3.59

north_east
$0.07 (1.85%)
Day's range
$3.48
Day's range
$3.62

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date
Details
01/31/2025 Piper Sandler Joseph Catanzaro $7.50 $5.85   28.21%
10/23/2024 UBS David Dai $17.00 $9.82   73.12%
08/09/2024 Stifel Nicolaus Benjamin Burnett $23.00 $3.97   479.35%
08/09/2024 Robert W. Baird Colleen Kusy $24.00 $3.97   504.53%
07/28/2024 Piper Sandler Joseph Catanzaro $10.00 $9.25   8.11%
06/20/2024 JMP Securities Reni Benjamin $23.00 $4.00   475%
05/31/2024 Stifel Nicolaus Benjamin Burnett $28.00 $4.44   530.63%
03/14/2024 Piper Sandler Joseph Catanzaro $19.00 $14.21   33.71%
12/08/2022 Goldman Sachs Madhu Kumar $6.00 $7.17   -16.32%
11/20/2022 Piper Sandler Joseph Catanzaro $11.00 $6.62   66.16%
04/04/2022 Robert W. Baird Colleen M. Kusy $30.00 $16.56   81.16%
01/04/2022 Wells Fargo Nick Abbott $25.00 $16.82   48.63%
05/18/2021 Barclays Peter Lawson $40.00 $16.33   144.95%

Iovance Biotherapeutics, Inc. FAQ's

Iovance Biotherapeutics, Inc. has been rated by research analysts at Piper Sandler, UBS, Stifel Nicolaus, Robert W. Baird, JMP Securities, Goldman Sachs in the past 90 days.